Elsevier

Brain Research

Volume 783, Issue 1, 2 February 1998, Pages 121-126
Brain Research

Research Report
Regional preferences of AMPA receptor modulators determined through agonist binding autoradiography

https://doi.org/10.1016/S0006-8993(97)01315-2Get rights and content

Abstract

Autoradiographic techniques were used to test if positive modulators of AMPA-type glutamate receptors have regionally differentiated effects on ligand binding. Cyclothiazide, a drug with ten fold greater effects on `flip' than `flop' splice variants of the receptors, had unequal effects across the subdivisions of hippocampus; i.e., it reduced [3H]AMPA binding in field CA3 with an EC50 of 24 μM and in field CA1 and dentate gyrus with EC50s between 60 and 100 μM. The EC50 for the drug's influence on binding was also significantly lower in the superficial than in the deeper layers of the neocortex, though these differences were not as pronounced as those in the hippocampus. The ampakine CX614, a compound with a modest preference for flop variants, had a slightly lower EC50 for its effects on [3H]AMPA binding in CA1 than in CA3. This result was confirmed with [3H]fluorowillardiine binding. The effects of the ampakine in neocortex tended to be greater in the deeper than superficial layers but this did not reach statistical significance. These results indicate that differential effects of modulators on AMPA receptor subunits are reflected in their relative potency across brain subdivisions. This raises the possibility that subclasses of positive modulators will exhibit a measurable degree of selectivity in their physiological and behavioral influences.

Introduction

AMPA receptors are oligomeric proteins assembled from four homologous subunits 6, 15. Each of the subunits occurs in alternatively spliced isoforms termed `flip' and `flop' [21]and in several variants with single amino acid substitutions resulting from RNA editing [18]. Studies of recombinant receptors expressed in non-neuronal cell lines indicate that virtually any combination of subunits can form a functional receptor, including those that contain a single subunit type. The balance between subunits and between subunit variants changes with age [19]and differs across populations of neurons [8]but recurring patterns have been identified [9]. A number of reports have indicated that biophysical properties of neuronal AMPA receptors such as calcium permeability and desensitization kinetics correlate closely with those predicted from the subunit type prevalent in the respective cells [8]. Together these results indicate that different brain regions utilize AMPA receptors that are distinctly different with regard to composition and function.

The regional variations noted above raise the possibility that drugs directed at AMPA receptors will have regionally differentiated effects. Several classes of compounds modulate the receptors in a non-competitive manner, two of which, generally referred to as ampakines and benzothiadiazides, are of particular interest with regard to selective actions within the brain. These drugs enhance and prolong AMPA receptor currents and accordingly may have therapeutic applications in conditions in which glutamatergic transmission is subnormal. Studies with recombinantly expressed homomeric receptors indicate that cyclothiazide, one of the benzothiadiazides, has an approximately ten-fold higher affinity for the flip variants of most AMPA receptor subunits 13, 14, 20. Moreover, recent studies have shown that cyclothiazide enhances currents with a lower EC50 (and thus with higher affinity) in patches from field CA3, an area of the hippocampus enriched in flip variants, as compared to patches from the flop enriched area CA1 [2]. Ampakines, to the extent that they discriminate between subunits in binding [13]and physiological experiments (Arai et al., in preparation), have a modest preference for the flop variants.

Based on these observations, ampakines and benzothiadiazides would be expected to produce distinguishably different regional patterns of AMPA receptor modulation. However, most of the results summarized above were collected using extrasynaptic receptors and there is evidence that the synaptic environment profoundly modifies the binding properties of AMPA receptors [10]. Ligand autoradiography provides a means for testing if ampakines and benzothiadiazides act in a regionally differentiated fashion vis-à-vis their effects on AMPA receptors in situ. Several AMPA receptor modulators have been found to increase or reduce the binding of agonists like [3H]AMPA to membranes isolated from rat brain 3, 4, 11, 16. Moreover, while the direction and magnitude of the changes depend on the particulars of the assay conditions, the EC50 values were found to closely approximate those obtained in physiological tests including those involving synaptic responses. The present study used binding autoradiography with [3H]AMPA and the recently introduced compound [3H]fluorowillardiine [12]to test if the relative potencies of cyclothiazide and an ampakine vary across brain regions according to the balance of flip vs. flop subunits and as predicted from homomeric receptor studies.

Section snippets

Materials and methods

Two-month old Sprague–Dawley rats were anaesthetized with ether and killed by decapitation. The brains were quickly removed and dissected after a brief immersion in ice-cold phosphate-buffered saline. Coronal sections 15 μm in thickness were collected from the mid-part of the brain such that they included the rostral part of the hippocampus. Three or four sections were mounted together on a collagen-coated slide and stored at −20°C until use. After thawing, the sections were washed three times

Results

Cyclothiazide was shown earlier to reduce [3H]AMPA binding to brain membranes [16]and to homomeric AMPA receptors composed of subunits GluR1 to 4 [13]when assays were carried out in the presence of SCN. A similar effect was observed in the present study using binding autoradiography as illustrated by the photographs on the left side of Fig. 1. A quantitative analysis of the effect of cyclothiazide over a concentration range of 10 to 500 μM is shown in Fig. 2. As expected for a non-competitive

Discussion

The EC50 values for cyclothiazide determined here are of the same order as those determined in rat brain membranes [11]and are comparable to the ∼10 μM affinities typically obtained in excised patch studies [22]. Similar conclusions apply for CX614; this drug enhanced EPSPs in hippocampal slices and AMPA receptor currents in patches from CA1 with EC50 values of 20–50 μM (Arai et al., in preparation), which is in the range of the values shown in Fig. 4. Thus, measuring the non-competitive

Acknowledgements

This research project was supported by grant CP-19982 from Cortex Pharmaceuticals, Irvine, and by grant 95-1-0304 from the Air Force Office for Scientific Research. The authors wish to thank Jackie Porter and Marla Lay for their secretarial assistance.

References (22)

  • S.J. Gold et al.

    Stoichiometries of AMPA receptor subunit mRNAs in rat brain fall into discrete categories

    J. Comp. Neurol.

    (1997)
  • Cited by (14)

    • AMPA receptor activation reduces epileptiform activity in the rat neocortex

      2007, Brain Research
      Citation Excerpt :

      When we applied cyclothiazide by itself there was a significant suppression of the P1 but not the N1 wave. Kessler et al. (1998) have reported that cyclothiazide is more effective in the outer than the inner cortical layers because of the predominance of the flip variants of AMPARs in cortical layers II and III. Such a situation could explain the greater effect of cyclothiazide on the P1 wave than the N1 in our experiments since the former represents activity in the superficial cortical layers whereas the latter reflects that in the deeper layers.

    • Mechanistic studies of capsaicin-induced apnea in rodents

      2017, American Journal of Respiratory Cell and Molecular Biology
    View all citing articles on Scopus
    View full text